- Home
- ELSE vs NXTC Comparison
ELSE vs NXTC Comparison
Compare ELSE & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELSE
- NXTC
- Stock Information
- Founded
- ELSE 1968
- NXTC 2015
- Country
- ELSE United States
- NXTC United States
- Employees
- ELSE N/A
- NXTC N/A
- Industry
- ELSE Industrial Machinery/Components
- NXTC Biotechnology: Pharmaceutical Preparations
- Sector
- ELSE Industrials
- NXTC Health Care
- Exchange
- ELSE Nasdaq
- NXTC Nasdaq
- Market Cap
- ELSE 13.2M
- NXTC 13.9M
- IPO Year
- ELSE N/A
- NXTC 2019
- Fundamental
- Price
- ELSE $4.18
- NXTC $0.48
- Analyst Decision
- ELSE
- NXTC Strong Buy
- Analyst Count
- ELSE 0
- NXTC 2
- Target Price
- ELSE N/A
- NXTC $3.50
- AVG Volume (30 Days)
- ELSE 76.9K
- NXTC 141.9K
- Earning Date
- ELSE 05-12-2025
- NXTC 05-01-2025
- Dividend Yield
- ELSE N/A
- NXTC N/A
- EPS Growth
- ELSE 14.32
- NXTC N/A
- EPS
- ELSE 0.11
- NXTC N/A
- Revenue
- ELSE $9,368,000.00
- NXTC N/A
- Revenue This Year
- ELSE N/A
- NXTC N/A
- Revenue Next Year
- ELSE N/A
- NXTC N/A
- P/E Ratio
- ELSE $38.01
- NXTC N/A
- Revenue Growth
- ELSE 7.01
- NXTC N/A
- 52 Week Low
- ELSE $3.65
- NXTC $0.22
- 52 Week High
- ELSE $5.50
- NXTC $1.82
- Technical
- Relative Strength Index (RSI)
- ELSE 52.35
- NXTC 52.82
- Support Level
- ELSE $3.75
- NXTC $0.46
- Resistance Level
- ELSE $4.32
- NXTC $0.52
- Average True Range (ATR)
- ELSE 0.29
- NXTC 0.04
- MACD
- ELSE 0.03
- NXTC 0.00
- Stochastic Oscillator
- ELSE 32.32
- NXTC 54.50
About ELSE Electro-Sensors Inc.
Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.